Back

Anti-cancer drug-induced atrial and ventricular arrhythmias.

28 August 2022 (16:45 - 17:00)
Organised by:
Congress Presentation Part of: Translational cardio-oncology: impact of anti-cancer drugs on the heart, vessels and rhythm Cardiac Diseases ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Joe Elie Salem

Sorbonne University, Paris (France)

3 More presentations in this session

Presentation thumbnail
Vascular, muscular and metabolic cardiac damage caused by anti-cancer drugs.
Doctor U. Campia (Boston, US)
Slides Video
Presentation thumbnail
Vascularised heart models for pre-clinical screening of cardiotoxicity.
Professor P. Van Der Meer (Groningen, NL)
Slides Video
Presentation thumbnail
Translational cardio-oncology: impact of anti-cancer drugs on the heart, vessels and rhythm – discussion.
Video

Access the full session

Session thumbnail
Translational cardio-oncology: impact of anti-cancer drugs on the heart, vessels and rhythm
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 16:45 CET
You may be interested in
thumbnail
Congress Presentation
How to manage arrhythmogenic cardiotoxicity and the risk of life-threatening ventricular arrhythmias and sudden cardiac death during cancer therapy?
21 June 2025
thumbnail
Congress Presentation
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation
20 June 2025
thumbnail
Congress Session
Sudden cardiac death: insight
31 August 2024
thumbnail
Congress Presentation
Check-point inhibition: cardiovascular consequences and their prevention
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources